These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4841307)

  • 1. Preliminary experience with a new low-oestrogen content combined oral contraceptive.
    Prsić J; Kićović PM
    Curr Med Res Opin; 1974; 2(4):204-10. PubMed ID: 4841307
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
    Jacobs C; Heinen G; Schmal E
    Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
    [No Abstract]   [Full Text] [Related]  

  • 3. [Restovar, a new combined oral contraceptive with a low estrogen content].
    Fondu F; Lowijck J
    Brux Med; 1974 Aug; 54(8):453-8. PubMed ID: 4425958
    [No Abstract]   [Full Text] [Related]  

  • 4. Lyndiol: evaluation of safety and efficacy as an oral contraceptive.
    Strade HA
    Curr Ther Res Clin Exp; 1966 May; 8(5):265-79. PubMed ID: 4956390
    [No Abstract]   [Full Text] [Related]  

  • 5. A Latin American field trial with a once-a-month oral contraceptive.
    Leguia AL
    J Reprod Med; 1973 Apr; 10(4):202-3. PubMed ID: 4695503
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
    Kaltreider DF
    Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tolerance of the normocyclic sequence drug Oraconal and of various neutral hormones as well as of gestagen emphasizing contraceptive agents in the medical practice. Results of a group study of 173 established gynecologists involving 1539 women].
    Erdmann G; Gelbhaar H; Pollter J
    Fortschr Med; 1973 Mar; 91(7):303-10. PubMed ID: 4720458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of restovar, an oral contraceptive with a low estrogen content].
    Molitor MP
    Bull Soc Sci Med Grand Duche Luxemb; 1975 May; 112(1):47-52. PubMed ID: 1149176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects, on the endometrium, of a new oral contraceptive: Physiostat].
    Delacroix P
    Rev Fr Gynecol Obstet; 1977; 72(7-9):583-5. PubMed ID: 905717
    [No Abstract]   [Full Text] [Related]  

  • 10. A new oral contraceptive based on the normophasic method.
    Bolle J; Poulain A
    Arzneimittelforschung; 1976; 26(3):441-3. PubMed ID: 989342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical experiences with gestagen therapy of various gynecologic diseases].
    György G; László J
    Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Central and peripheral actions of an oral contraceptive with reduced oestrogen content (author's transl)].
    Schneider WH; Schmid R; Spona J
    Wien Klin Wochenschr; 1977 Apr; 89(9):311-3. PubMed ID: 855349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of antithrombin III. Comparison of six methods. Effect of oral contraceptive therapy.
    Bounameaux H; Duckert F; Walter M; Bounameaux Y
    Thromb Haemost; 1978 Jun; 39(3):607-15. PubMed ID: 705689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The search for new ways with low dose contraceptives. II].
    Tóth F; Gimes R; Horn B; Kerényi T
    Z Arztl Fortbild (Jena); 1972 Oct; 66(20):1021-5. PubMed ID: 4651027
    [No Abstract]   [Full Text] [Related]  

  • 16. Ovanon. A new sequential oral contraceptive.
    Rice-Wray E; Peña A; Maqueo M
    Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled trial of oral contraceptives in haemophilia.
    Beck P; Bloom AL; Giddings JC; Sweetnam PM
    Br J Haematol; 1970 Dec; 19(6):667-73. PubMed ID: 4923835
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
    Gaspard UJ; Deville JL; Dubois M
    Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of oral contraceptives in haemophilia.
    Brandt NJ; Cohn J; Hilden M
    Scand J Haematol; 1973; 11(3):225-9. PubMed ID: 4587789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives: therapeutics versus adverse reactions, with an outlook for the future I.
    Bingel AS; Benoit PS
    J Pharm Sci; 1973 Feb; 62(2):179-200. PubMed ID: 4568621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.